nodes	percent_of_prediction	percent_of_DWPC	metapath
Tyloxapol—LPL—Retinoid metabolism and transport—LRP12—glaucoma	0.13	0.147	CbGpPWpGaD
Tyloxapol—LPL—Composition of Lipid Particles—APOE—glaucoma	0.0738	0.0834	CbGpPWpGaD
Tyloxapol—LPL—Diseases associated with visual transduction—LRP12—glaucoma	0.0664	0.075	CbGpPWpGaD
Tyloxapol—LPL—Chylomicron-mediated lipid transport—APOE—glaucoma	0.0444	0.0502	CbGpPWpGaD
Tyloxapol—LPL—Statin Pathway—ABCA1—glaucoma	0.044	0.0497	CbGpPWpGaD
Tyloxapol—LPL—Lipoprotein metabolism—ABCA1—glaucoma	0.0428	0.0484	CbGpPWpGaD
Tyloxapol—LPL—eye—glaucoma	0.0391	0.338	CbGeAlD
Tyloxapol—LPL—retina—glaucoma	0.0387	0.335	CbGeAlD
Tyloxapol—LPL—connective tissue—glaucoma	0.0376	0.326	CbGeAlD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.0304	0.0344	CbGpPWpGaD
Tyloxapol—LPL—Statin Pathway—APOE—glaucoma	0.0289	0.0327	CbGpPWpGaD
Tyloxapol—LPL—Lipid and lipoprotein metabolism—ABCA1—glaucoma	0.0285	0.0322	CbGpPWpGaD
Tyloxapol—LPL—Lipoprotein metabolism—APOE—glaucoma	0.0282	0.0318	CbGpPWpGaD
Tyloxapol—LPL—Retinoid metabolism and transport—APOE—glaucoma	0.0219	0.0248	CbGpPWpGaD
Tyloxapol—LPL—Lipid and lipoprotein metabolism—APOE—glaucoma	0.0187	0.0212	CbGpPWpGaD
Tyloxapol—LPL—Lipid and lipoprotein metabolism—CAV1—glaucoma	0.0185	0.021	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—FAS—glaucoma	0.0141	0.016	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.0137	0.0155	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.013	0.0147	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—APOE—glaucoma	0.013	0.0147	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—BAD—glaucoma	0.0121	0.0137	CbGpPWpGaD
Tyloxapol—LPL—Diseases associated with visual transduction—APOE—glaucoma	0.0112	0.0127	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.0108	0.0122	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.00989	0.0112	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—NR3C1—glaucoma	0.0098	0.0111	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—FAS—glaucoma	0.00949	0.0107	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CA5A—glaucoma	0.00932	0.0105	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NARFL—glaucoma	0.00932	0.0105	CbGpPWpGaD
Tyloxapol—LPL—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.00925	0.0105	CbGpPWpGaD
Tyloxapol—LPL—Disease—LRP12—glaucoma	0.00843	0.00953	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—NCK2—glaucoma	0.00839	0.00949	CbGpPWpGaD
Tyloxapol—LPL—Transcriptional regulation of white adipocyte differentiation—TNF—glaucoma	0.00613	0.00693	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—TNF—glaucoma	0.006	0.00679	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—LRP12—glaucoma	0.0059	0.00667	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—PAX6—glaucoma	0.00544	0.00615	CbGpPWpGaD
Tyloxapol—LPL—Disease—FGFR1OP—glaucoma	0.00543	0.00614	CbGpPWpGaD
Tyloxapol—LPL—Disease—HEYL—glaucoma	0.00543	0.00614	CbGpPWpGaD
Tyloxapol—LPL—Alzheimers Disease—TP53—glaucoma	0.00529	0.00598	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CA1—glaucoma	0.00455	0.00514	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CTSA—glaucoma	0.00441	0.00498	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CA2—glaucoma	0.00416	0.0047	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—OPN4—glaucoma	0.00409	0.00463	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	0.00407	0.0046	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	0.00407	0.0046	CbGpPWpGaD
Tyloxapol—LPL—Adipogenesis—TNF—glaucoma	0.00403	0.00456	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HEYL—glaucoma	0.0038	0.0043	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—PTGFR—glaucoma	0.00368	0.00416	CbGpPWpGaD
Tyloxapol—LPL—Disease—HDAC9—glaucoma	0.00339	0.00383	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—TXN—glaucoma	0.00293	0.00331	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—RPTOR—glaucoma	0.00288	0.00326	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NCK2—glaucoma	0.00279	0.00316	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—APOE—glaucoma	0.00267	0.00302	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—CAV1—glaucoma	0.00265	0.003	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MMP2—glaucoma	0.0024	0.00271	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—HDAC9—glaucoma	0.00237	0.00268	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTT1—glaucoma	0.00227	0.00257	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—SMO—glaucoma	0.00186	0.0021	CbGpPWpGaD
Tyloxapol—LPL—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	0.00183	0.00207	CbGpPWpGaD
Tyloxapol—LPL—Disease—CDKN2B—glaucoma	0.00182	0.00206	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CYP1B1—glaucoma	0.00181	0.00205	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—ABCA1—glaucoma	0.00181	0.00205	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—MMP9—glaucoma	0.0018	0.00204	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NTRK2—glaucoma	0.0017	0.00192	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—VEGFA—glaucoma	0.00162	0.00183	CbGpPWpGaD
Tyloxapol—LPL—Disease—MTHFR—glaucoma	0.00153	0.00173	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NGFR—glaucoma	0.00146	0.00165	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—GSTM1—glaucoma	0.00145	0.00164	CbGpPWpGaD
Tyloxapol—LPL—Disease—APOE—glaucoma	0.00142	0.00161	CbGpPWpGaD
Tyloxapol—LPL—Disease—CAV1—glaucoma	0.00141	0.00159	CbGpPWpGaD
Tyloxapol—LPL—Developmental Biology—TNF—glaucoma	0.00139	0.00157	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NTRK1—glaucoma	0.00139	0.00157	CbGpPWpGaD
Tyloxapol—LPL—Disease—BAD—glaucoma	0.00133	0.0015	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—MTHFR—glaucoma	0.00128	0.00145	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CDKN2B—glaucoma	0.00128	0.00144	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—EDN1—glaucoma	0.00122	0.00138	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—APOE—glaucoma	0.00119	0.00135	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—CAV1—glaucoma	0.00118	0.00133	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NGF—glaucoma	0.00113	0.00127	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—C3—glaucoma	0.00107	0.00121	CbGpPWpGaD
Tyloxapol—LPL—Disease—NOS3—glaucoma	0.00107	0.0012	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—APOE—glaucoma	0.000996	0.00113	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CAV1—glaucoma	0.000987	0.00112	CbGpPWpGaD
Tyloxapol—LPL—Disease—PTGS2—glaucoma	0.000975	0.0011	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—FN1—glaucoma	0.000939	0.00106	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—BAD—glaucoma	0.000928	0.00105	CbGpPWpGaD
Tyloxapol—LPL—Disease—CDKN1B—glaucoma	0.000923	0.00104	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—NOS3—glaucoma	0.000892	0.00101	CbGpPWpGaD
Tyloxapol—LPL—Metabolism—PTGS2—glaucoma	0.000816	0.000923	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—NOS3—glaucoma	0.000746	0.000844	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—CDKN1B—glaucoma	0.000646	0.000731	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—MMP9—glaucoma	0.000599	0.000677	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—VEGFA—glaucoma	0.000538	0.000608	CbGpPWpGaD
Tyloxapol—LPL—Signaling Pathways—TP53—glaucoma	0.000406	0.000459	CbGpPWpGaD
